Chemoinformaics analysis of 2,3-Dihydro-2-methylbenzofuran
| Molecular Weight | 134.178 | nRot | 0 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 10 |
| Exact Molecular Weight | 134.073 | nRing | 2 |
| Solubility: LogS | -3.188 | nHRing | 1 |
| Solubility: LogP | 2.896 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 22.4999 |
| nHD | 0 | BPOL | 11.7681 |
| QED | 0.527 |
| Synth | 2.23 |
| Natural Product Likeliness | 0.197 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.005 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.368 |
| MDCK | 0.0000306 |
| BBB | 0.638 |
| PPB | 0.917173 |
| VDSS | 1.378 |
| FU | 0.0770926 |
| CYP1A2-inh | 0.938 |
| CYP1A2-sub | 0.676 |
| CYP2c19-inh | 0.72 |
| CYP2c19-sub | 0.398 |
| CYP2c9-inh | 0.08 |
| CYP2c9-sub | 0.472 |
| CYP2d6-inh | 0.371 |
| CYP2d6-sub | 0.877 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.343 |
| CL | 12.247 |
| T12 | 0.565 |
| hERG | 0.02 |
| Ames | 0.535 |
| ROA | 0.027 |
| SkinSen | 0.349 |
| Carcinogencity | 0.878 |
| EI | 0.963 |
| Respiratory | 0.041 |
| NR-Aromatase | 0.031 |
| Antiviral | No |
| Prediction | 0.895163 |